Artiva Biotherapeutics, Inc. — Balance Sheet Charts
4 snapshots of history · ending 2024-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets
$210M
Current Assets
$189M
Cash & Equivalents
$40M
ST Investments
$145M
Receivables
$0
Net PPE
$6M
Total Liabilities
$23M
Current Liabilities
$12M
Account Payables
$1M
Stockholders Equity
$187M
Retained Earnings
$-247M
Operating Lease ROU Asset
$14M
Operating Lease Liability
$11M
Finance Lease ROU Asset
$261K
Gross PP&E
$12M
Accumulated Depreciation
$6M